Ann Wieben, a UW Clinical Trials Institute colleague, discusses her research on the use of machine learning/artificial intelligence in nursing. Ann is a clinical research program specialist at UW Health and a Ph.D. candidate in the UW–Madison School of Nursing....
With new support from the National Institutes of Health, a team of researchers at the Wisconsin Institute of Discovery will lead drug therapeutics testing for two diseases known to cause blindness....
Researchers at the University of Wisconsin–Madison’s Center for Healthy Minds are leveraging artificial intelligence to deliver personalized well-being content through a person’s mobile device when they need it most....
Vaccines for heart disease and cancer could help combat these diseases and advance researchers' understanding of the human body, but are they the magic cure-all many expect them to be?...
The U.S. Food and Drug Administration is taking additional steps to support the use of decentralized clinical trials (DCTs) for drugs, biologics and devices, where some or all the trial-related activities occur at locations other than traditional clinical trial sites....
A newly released series of reports from the University of Wisconsin–Madison showcases how the university connects with each of Wisconsin’s 72 counties....
UW Health is among three health care providers using artificial intelligence developed by Microsoft Corp. to draft message responses in electronic medical records by Verona-based Epic Systems....
Betsy Nugent, chief clinical research officer at the UW School of Medicine and Public Health and UW Health, appeared on Wisconsin Public Radio to discuss clinical trials at UW-Madison, including the importance of trials, how they operate, and the critical need to increase the diversity...
UW researchers have new genomic tools for explaining who we are and improving lives....
The US Food and Drug Administration (FDA) plans to hold at least one public meeting and release several guidances on digital health technologies (DHT) to be used in drug clinical trials by the end of the year....
